December 2025 – MedTech Matters

Staloral Birch Phase III Study Reports Positive Results in Pediatric Allergy Treatment

Biotech/Pharma / December 1, 2025

Allergic rhinoconjunctivitis affects more than 500 million people worldwide, with children facing particular challenges including sleep disruption, missed school days, and increased asthma risk. Stallergenes Greer announced that its Phase IIIb clinical study for Staloral Birch, a sublingual allergen immunotherapy, […]

Staloral Birch Phase III Study Reports Positive Results in Pediatric Allergy Treatment Read More »

Alabama Nonprofit Receives Grant for Vision Research Equipment

Innovation / December 1, 2025

Cell-based therapies for eye diseases remain an area of active research as organizations work to address the gap between available treatments and the prevalence of vision loss worldwide. Advancing Sight Network, an Alabama-based nonprofit, has received a $25,000 grant from

Alabama Nonprofit Receives Grant for Vision Research Equipment Read More »

Green Nanotechnology Shows Promise for Sustainable Implantable Biosensors in Medical Applications

Innovation / December 1, 2025

Toxic chemicals used to manufacture implantable biosensors may soon be replaced by plant extracts and bacteria. Researchers at IUBAT-International University of Business Agriculture and Technology published a comprehensive literature review examining how “green” nanotechnology could transform biosensor production, reducing environmental

Green Nanotechnology Shows Promise for Sustainable Implantable Biosensors in Medical Applications Read More »